From Medscape Oncology

Medscape Medical News from the:

European Cancer Congress 2013 (ECCO-ESMO-ESTRO)

September 27 - October 01, 2013; Amsterdam, the Netherlands

This coverage is not sanctioned by, nor a part of the European Cancer Organization, the European Society for Medical Oncology, or the European Society for Radiation and Oncology.

Meeting Highlights at a Glance

Top News From ECC 2013 (ECCO-ESMO-ESTRO): Slideshow
Highlights include promising immunotherapeutic agents for melanoma and lung cancer; treatment trials in ovarian and breast cancer, plus a special report on global disparities in oncology.

Genomics in Practice at the 2013 European Cancer Congress
Dr. Maurie Markman looks at a few presentations from the 2013 European Cancer Congress that highlight the practical role of genetic testing in the management of cancer.

Conference News

Medscape Oncology©  WebMD, LLC

Medscape Oncology Insights

Oncologists Initiate Upgrade of European Cancer Care
David Kerr, CBE, MD, DSc, FRCP, FMedSci; Cornelis J.H. van de Velde, MD, PhD

Prostate Cancer: Enough 'Me Too’ Drugs
Stéphane Oudard, MD, PhD;
Bertrand Tombal, MD, PhD

Bevacizumab: Mixed Results in Glioblastoma
Wolfgang Wick, MD

Ipilimumab Goes the Distance in Melanoma Survival
Antoni Ribas, MD, PhD;
Caroline Robert, MD, PhD

New ALK Agents: Lung Cancer's 'Second Miracle'?
Giorgio V. Scagliotti, MD, PhD;
D. Ross Camidge, MD, PhD

TDM-1 Heavy Hitter in Heavily Treated Breast Cancer
Joseph Gligorov, MD, PhD;
Javier Cortés, MD, PhD

TKI Hikes Survival in Recurrent Ovarian Cancer
Stanley B. Kaye, MD

HPV Head and Neck Cancer: The New Threat
Linda Brookes, MSc